secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0001193125-23-240513
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex raises ~$582,500 via private placement of 3.7M shares at $0.156/sh
---------------------------------------------------------------------------

- Sold 3,733,973 common shares at $0.156/sh to accredited investors for gross proceeds of ~$582,500.
- CEO-controlled entity Vaccinex (Rochester), L.L.C. participated in the placement.
- Company granted registration rights for resale of shares within 180 days of closing.
- Proceeds to fund pepinemab development and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523240513/0001193125-23-240513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523240513/d684317d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-240513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer